Terms: = Bone cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6 AND Treatment
5 results:
1. The downregulation of IGFBP3 by TGF-β signaling in oral cancer contributes to the osteoclast differentiation.
Park J; Jung MJ; Chung WY
Biochem Biophys Res Commun; 2021 Jan; 534():381-386. PubMed ID: 33256984
[TBL] [Abstract] [Full Text] [Related]
2. Depletion of MOB1A/B causes intestinal epithelial degeneration by suppressing Wnt activity and activating BMP/TGF-β signaling.
Bae JS; Jeon Y; Kim SM; Jang JY; Park MK; Kim IH; Hwang DS; Lim DS; Lee H
Cell Death Dis; 2018 Oct; 9(11):1083. PubMed ID: 30349003
[TBL] [Abstract] [Full Text] [Related]
3. CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.
Yan HH; Jiang J; Pang Y; Achyut BR; Lizardo M; Liang X; Hunter K; Khanna C; Hollander C; Yang L
Cancer Res; 2015 Dec; 75(24):5283-98. PubMed ID: 26483204
[TBL] [Abstract] [Full Text] [Related]
4. Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer.
Jackson RS; Placzek W; Fernandez A; Ziaee S; Chu CY; Wei J; Stebbins J; Kitada S; Fritz G; Reed JC; Chung LW; Pellecchia M; Bhowmick NA
Neoplasia; 2012 Jul; 14(7):656-65. PubMed ID: 22904682
[TBL] [Abstract] [Full Text] [Related]
5. Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
Tan AR; Alexe G; Reiss M
Breast Cancer Res Treat; 2009 Jun; 115(3):453-95. PubMed ID: 18841463
[TBL] [Abstract] [Full Text] [Related]
